Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma.

Kim KI, Chung HK, Park JH, Lee YJ, Kang JH.

World J Gastroenterol. 2016 Jul 21;22(27):6127-34. doi: 10.3748/wjg.v22.i27.6127. Review.

2.

Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Stei MM, Loeffler KU, Holz FG, Herwig MC.

Biomed Res Int. 2016;2016:4521807. doi: 10.1155/2016/4521807. Epub 2016 Jun 6. Review.

3.

Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.

Kozlowska AK, Kaur K, Topchyan P, Jewett A.

Cancer Immunol Immunother. 2016 Jul;65(7):835-45. doi: 10.1007/s00262-016-1822-9. Epub 2016 Mar 31. Review.

PMID:
27034236
4.

Current State of Animal (Mouse) Modeling in Melanoma Research.

Kuzu OF, Nguyen FD, Noory MA, Sharma A.

Cancer Growth Metastasis. 2015 Oct 6;8(Suppl 1):81-94. doi: 10.4137/CGM.S21214. eCollection 2015. Review.

5.

Molecular and clinical implementations of ovarian cancer mouse avatar models.

Zayed AA, Mandrekar SJ, Haluska P.

Chin Clin Oncol. 2015 Sep;4(3):30. doi: 10.3978/j.issn.2304-3865.2015.04.01. Review.

6.

Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.

Min JW, Kim WJ, Han JA, Jung YJ, Kim KT, Park WY, Lee HO, Choi SS.

PLoS One. 2015 Aug 25;10(8):e0135817. doi: 10.1371/journal.pone.0135817. eCollection 2015.

7.

Patient-derived cell models as preclinical tools for genome-directed targeted therapy.

Lee JY, Kim SY, Park C, Kim NK, Jang J, Park K, Yi JH, Hong M, Ahn T, Rath O, Schueler J, Kim ST, Do IG, Lee S, Park SH, Ji YI, Kim D, Park JO, Park YS, Kang WK, Kim KM, Park WY, Lim HY, Lee J.

Oncotarget. 2015 Sep 22;6(28):25619-30. doi: 10.18632/oncotarget.4627.

8.

A better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivo.

Wang H, Li W, Lai B, Yang X, Zhang C, Li J, Zhu Y.

Anticancer Drugs. 2015 Sep;26(8):852-9. doi: 10.1097/CAD.0000000000000259.

9.

The promise and challenge of ovarian cancer models.

Hasan N, Ohman AW, Dinulescu DM.

Transl Cancer Res. 2015 Feb;4(1):14-28.

10.

Tumor microenvironment: a new treatment target for cancer.

Tsai MJ, Chang WA, Huang MS, Kuo PL.

ISRN Biochem. 2014 Apr 10;2014:351959. doi: 10.1155/2014/351959. eCollection 2014. Review.

11.

A deletion in FOXN1 is associated with a syndrome characterized by congenital hypotrichosis and short life expectancy in Birman cats.

Abitbol M, Bossé P, Thomas A, Tiret L.

PLoS One. 2015 Mar 17;10(3):e0120668. doi: 10.1371/journal.pone.0120668. eCollection 2015.

12.

Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.

Ohman AW, Hasan N, Dinulescu DM.

Front Oncol. 2014 Nov 18;4:322. doi: 10.3389/fonc.2014.00322. eCollection 2014. Review.

13.

The progression of cell death affects the rejection of allogeneic tumors in immune-competent mice - implications for cancer therapy.

Chaurio RA, Muñoz LE, Maueröder C, Janko C, Harrer T, Fürnrohr BG, Niederweis M, Bilyy R, Schett G, Herrmann M, Berens C.

Front Immunol. 2014 Nov 11;5:560. doi: 10.3389/fimmu.2014.00560. eCollection 2014.

14.

Prediction of individual response to anticancer therapy: historical and future perspectives.

Unger FT, Witte I, David KA.

Cell Mol Life Sci. 2015 Feb;72(4):729-57. doi: 10.1007/s00018-014-1772-3. Epub 2014 Nov 12. Review.

15.

Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL/6 nude mice.

Stemmer K, Kotzbeck P, Zani F, Bauer M, Neff C, Müller TD, Pfluger PT, Seeley RJ, Divanovic S.

Int J Obes (Lond). 2015 May;39(5):791-7. doi: 10.1038/ijo.2014.187. Epub 2014 Oct 28.

16.

Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era.

Veinotte CJ, Dellaire G, Berman JN.

Dis Model Mech. 2014 Jul;7(7):745-54. doi: 10.1242/dmm.015784. Review.

17.

The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma.

Wang F, Dai W, Wang Y, Shen M, Chen K, Cheng P, Zhang Y, Wang C, Li J, Zheng Y, Lu J, Yang J, Zhu R, Zhang H, Zhou Y, Xu L, Guo C.

PLoS One. 2014 May 9;9(5):e97414. doi: 10.1371/journal.pone.0097414. eCollection 2014.

18.

An immunocompetent, orthotopic mouse model of epithelial ovarian cancer utilizing tissue engineered tumor cell sheets.

Arauchi A, Yang CH, Cho S, Jarboe EA, Peterson CM, Bae YH, Okano T, Janát-Amsbury MM.

Tissue Eng Part C Methods. 2015 Jan;21(1):23-34. doi: 10.1089/ten.TEC.2014.0040.

19.

A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.

Yang X, Cui W, Yu S, Xu C, Chen G, Gu A, Li T, Cui Y, Zhang X, Bian X.

PLoS One. 2014 Jan 15;9(1):e85759. doi: 10.1371/journal.pone.0085759. eCollection 2014.

20.

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.

Grinde MT, Skrbo N, Moestue SA, Rødland EA, Borgan E, Kristian A, Sitter B, Bathen TF, Børresen-Dale AL, Mælandsmo GM, Engebraaten O, Sørlie T, Marangoni E, Gribbestad IS.

Breast Cancer Res. 2014 Jan 21;16(1):R5. doi: 10.1186/bcr3597.

Items per page

Supplemental Content

Write to the Help Desk